|
|
|
Bykova E., Sogolovskaya E., Sotnikova T., Gabriel T. ANALYSIS OF CHANGES IN THE FACTORS OF NONSPECIFIC PROTECTION OF BIOLOGICAL FLUIDS IN VIRAL LESIONS OF THE EYES SURFACEIt is known that in adenoviral conjunctivitis, herpes and other infectious diseases in the human body increases the production of specific and nonspecific protection factors. Nonspecific factors include lysozyme (muramidase) and ceruloplasmin, which form together with other factors, antibacterial, antiviral and antiradical body protection (ABP, AVP, ARP). Adenoviral infection first develops in the nasopharynx, and then raises along tear duct, and involves in the pathological process the conjunctiva and lacrimal apparatus of the eye. The virus of herpes resides in the human body in a latent state and, periodically sharpening, causes ophthalmic herpes. Individual drugs used in ophthalmology for the treatment of viral infections (adenoviral keratoconjunctivitis and ophthalmic herpes), have the ability to inhibit the lysozyme activity (e.g., cycloferon, interferon and poludan). The enzyme activity of ceruloplasmin depends on the chemical structure of a drug and additionally introduced ingredients.Key words: adenoviral keratoconjunctivitis, ophthalmic herpes, ceruloplasmin, lysozyme, lacrimal fluid.
References:
1. Danilov A.B. Diclofenac in treatment of pain syndromes // The attending physicianš— 2009.š— №5š— p. 34-36.
2. Kasparov A. A. Ophthalmoherpes.š— M.: Medicineš— 1994š— p. 224.
3. Kamyshnikov V.S. Determination of (activity) perulloplazmina // Reference Klinko and biochemical research and laboratory diagnosticsš— M: MEDpressš— – 2009š— p.71-75.
4. L. V. Kletikova The impact of vaccination on lysozyme activity // Veterinary Medicineš— 2009š— №2š— p.19-20.
5. Mazurik N. Overcome the microbes without dangerous consequences // Science and Technology of Russiaš— 2008š— №3š— p.28-30 .
6. Mashkovskii M.D. Drugsš— Kharkiv: Torsingš— 1996š— 1,2 v .
7. Meckler L. B., Iddis R. G. Construction of three-dimensional models of molecules of protein egg lysozymeš— M.: Medicineš— 1981.
8. Molchanov D. Adenovirus infection in HH1 century : traditional knowledge against humanity against a multifaceted enemyš— Kiev : how healthy Iš— 2009š— №16 / 1š— p. 48-50
9. Osidze D. F., Prostyakov A. N. Factors of resistance of animals // Veterinary Medicine, 1983š— №3š— p.32-34 .
10. Register of medicines in Russia. Encyclopedia of medicines.š— M.: radars, 2005.š— p. 1392.
11. Dig A. Fundamentals of Immunology // M.: the Worldš— 1991 –p. 328.
12. Sokhin A.A., E.F. Chernushenko Applied Immunologyš— Kiev: how healthy Iš— 1984š— 316 p.
13. Storozhuk P. G., Storozhuk I. A., Artamonov V. A., Artamonov M. V., Action proprietary dental anti-inflammatory drugs in the non-specific protective factors of saliva // Herald of Intensive Careš— 2006š— №5.š— p. 346-347.
14. Usov A. I. Peptidoglycans. Directory. Chemical Encyclopedia. M: Soviet Encyclopediaš— 1988.
15. Hamilton R. The Herpes book. Los Angeles.š— 1980.
16. Nga Hyuing Important parameters of copper in the facility for treatment of wounds // Cooper peptide technologyš— 2010.
17. Murray R.K., Granner D.K., Mayes P.A., Rodwell V.W. Harper`s Biochemistry // Prentice-Hall Internetional Londonš— 1993.
About this article
Authors: Bykova E.V., Gabriel T.P., Sogolovskaya E.E., Sotnikova T.O.
Year: 2015
|
|
Editor-in-chief |
Sergey Aleksandrovich MIROSHNIKOV |
|
|